SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-19-003577
Filing Date
2019-03-21
Accepted
2019-03-21 07:44:14
Documents
8
Period of Report
2019-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp103822_6k.htm 6-K 15036
2 EXHIBIT 99.1 dp103822_ex9901.htm EX-99.1 67584
3 EXHIBIT 99.2 dp103822_ex9902.htm EX-99.2 206984
4 EXHIBIT 99.3 dp103822_ex9903.htm EX-99.3 146181
5 GRAPHIC image_001.jpg GRAPHIC 3194
6 GRAPHIC image_003.gif GRAPHIC 1740
7 GRAPHIC image_004.jpg GRAPHIC 6987
8 GRAPHIC image_005.jpg GRAPHIC 2964
  Complete submission text file 0000950103-19-003577.txt   457692
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 19695922
SIC: 2834 Pharmaceutical Preparations